FOXO4-DRI – 10MG – OptimalPep

Bundle	Quantity	Discount
Buy 3 Vials	3	5% OFF
Buy 5 Vials	5	8% OFF
Buy 6+ Vials BEST VALUE	6 – 9	10% OFF

Bundle

Quantity

Discount

Buy 3 Vials

5% OFF

Buy 5 Vials

8% OFF

Buy 6+ Vials BEST VALUE

6 – 9

10% OFF

Advanced Senolytic Research Peptide

Senescent Cell Targeting Research System

FOXO4-DRI is an experimental senolytic peptide studied for its ability to disrupt the FOXO4-p53 protein interaction and promote apoptosis in senescent cells across cellular aging, senescence clearance, tissue rejuvenation, age-related fitness, hair-loss, renal, and hepatic research models.

🧬 Senolytic Focus

Senescent cell clearance research

🔗 FOXO4-p53

Protein-interaction pathway studies

♻️ Cellular Renewal

Tissue rejuvenation research models

🔬 Research Grade

Cellular senescence investigation

3rd Party Tested

USA Made

COA Available

High Demand

Only 9 left in stock

Designed for advanced senolytic research

Precision research peptide with broad relevance to senescent-cell clearance, FOXO4-p53 signaling, apoptosis, cellular aging, and tissue-rejuvenation studies.

Research Peptide Price

Flexible checkout available

or 4 payments with Klarna

Add FOXO4-DRI to Research Cart

⚠️ For research use only. Not for human or veterinary use.

Product Description

Senescent Cell-Targeted Research Peptide

🧪

3rd Party
Tested

🇺🇸

Made in
USA

📄

COA
Available

FOXO4-DRI is an experimental senolytic peptide studied for its potential ability to selectively target senescent cells, sometimes referred to as “zombie cells.” These cells have permanently stopped dividing but remain metabolically active and may release pro-inflammatory signaling factors. FOXO4-DRI is commonly examined in research models involving FOXO4-p53 interaction disruption, senescent-cell apoptosis, cellular aging, and tissue rejuvenation.

Key Research Areas

🧬 Senolytic activity and senescent-cell clearance in laboratory models examining permanently non-dividing, metabolically active cells

🔗 FOXO4-p53 protein-interaction disruption to investigate the release and relocation of p53 within senescent-cell models

♻️ Apoptosis signaling in senescent cells and its potential role in reducing accumulated senescent-cell burden

🧓 Cellular aging and tissue-rejuvenation studies evaluating age-related fitness, cellular function, and inflammatory signaling markers

🧪 Preclinical organ and tissue models involving hair loss, renal decline, hepatic decline, and other age-associated cellular changes

This 10 mg presentation supports controlled senolytic research designs, making it suitable for investigations across cellular senescence, FOXO4-p53 signaling, apoptosis, inflammatory signaling, tissue function, and age-related cellular decline.

Intended Use

📦 Format: Lyophilized powder (10mg)
⚠️ Use: For laboratory research use only. Not for human or veterinary use.

Why Researchers Choose This Compound

🎯 Focused senescent-cell targeting supports precise investigation into the mechanisms responsible for senescent-cell survival and clearance.

🧪 Distinct FOXO4-p53 research pathway makes it useful for examining protein interactions, p53 localization, apoptosis signaling, and cellular senescence.

📈 Broad age-related research value offers a controlled framework for studying cellular aging, inflammatory signaling, tissue function, hair-loss models, and renal or hepatic decline.

Product Notes

✅ Research category: Senolytic and cellular-senescence signaling

✅ Study context: Laboratory and non-clinical research models

✅ Compound focus: FOXO4-p53 interaction disruption, senescent-cell apoptosis, inflammatory signaling, cellular aging, and tissue-rejuvenation pathways